ACTICCA-1
17 Dec 2020
ACTICCA-1
ACTRN12615001283561
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)
Universitsklinikum Hamburg-Eppendorf
Cancer Type | Other |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | Gall Bladder |
Cancer Stage | All stages |
Anticipated Start Date | 2014-04-01 |
Anticipated End Date | 2022-04-01 |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | Professor Chris Karapetis |
Recruitment Status | Recruiting |